ZBH — Zimmer Biomet Holdings, Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Zimmer Biomet Holdings,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	446	291	1,025	905	705
Depreciation
Deferred Taxes
Non-Cash Items	352	443	97.3	101	90.2
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-134	-311	-396	-455	-105
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,499	1,285	1,582	1,499	1,697
Capital Expenditures	-417	-446	-689	-597	-577
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-86.4	-83	-89.7	-291	-1,398
Acquisition of Business
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-504	-529	-779	-888	-1,976
Financing Cash Flow Items	-173	466	-26.1	-38.9	-65.5
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,306	-844	-764	-485	326
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-324	-103	40.1	110	66.4